Cystatin D (Cystatin D (CYTD))

Cystatin D is a cysteine proteinase inhibitor, encoded by the CST5 gene, and predominantly found in human saliva and tears as part of the type 2 cystatins superfamily[4][7]. It inhibits cathepsins S, H, and L (but not B), playing a protective role against proteases within the oral cavity as well as broader physiological functions[7]. Cystatin D exhibits tissue-restricted expression, notably in the parotid gland, and is less widely distributed than other cystatins[1]. Beyond protease inhibition, it modulates cellular processes relevant to cancer, including suppression of proliferation, migration, invasion, and induction of adhesion in colon carcinoma cells[2][3][5]. Recent studies show that cystatin D can localize to the cell nucleus where it regulates transcription of specific genes, influencing key pathways such as EMT and Wnt signaling, thereby acting as a candidate tumor suppressor regulated in part by vitamin D[3][5]. While it is not a receptor, transporter, or enzyme, it functions as a therapeutic target due to its regulatory and protective roles in oncogenesis, immunity, and possibly neuroprotection[6]. No direct small-molecule drugs currently target cystatin D, but modulation of its pathway by vitamin D is noted[3][5].

Other names

CST5CYTDCystatin-D

Inhibition of lysosomal and secreted cysteine proteases; Suppression of cell cycle signaling pathways (e.g., Wnt/β-catenin/c-MYC); Promotion of cell adhesion proteins (e.g., E-cadherin); Reduction of pro-tumor cytokine secretion.